Currently, pharmaceutical drugs such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin (Ang) II type 1 receptor (AT1R) blockers are the first-line therapy for hypertension, but they are associated with various adverse effects such as dry cough and angioedema over a prolonged use [1]. The gene discussed is ACE; the disease is angioedema.